ITI Pharma and Healthcare Fund Regular vs SBI Healthcare Opportunities Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹227 Cr | ₹3963 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 31 Dec 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 32% |
Expense Ratio | 2.35 | 1.94 |
Manager | Rohan Korde | Pradeep Kesavan |
ISIN Code | INF00XX01BL5 | INF200K01446 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
1 Month | 0.58% | 0.49% |
6 Month | 10.76% | 10.17% |
1 Year | -3.83% | 3.11% |
3 Year | 22.08% | 26.25% |
5 Year | - | 19.97% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
6 Month | 1.94% | 2.71% |
1 Year | 3.79% | 8.35% |
3 Year | 19.77% | 24.24% |
5 Year | - | 21.01% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
1 Year | 19.5% | 16.04% |
3 Year | 19.53% | 17.71% |
5 Year | - | 12.85% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Standard Deviation | 15.57% | 13.91% |
Sharp | 0.86% | 1.28% |
Beta | 0.95% | 0.84% |
Alpha | -2.07% | 4.16% |
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Name | Rohan Korde | Pradeep Kesavan |
Total AUM | ₹4626 Cr | ₹434274 Cr |
Funds Managed | 10 | 43 |
ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Others | 3.17 | 12.03 |
Mid Cap | 37.04 | 27.95 |
Small Cap | 32.68 | 33.75 |
Large Cap | 27.1 | 26.26 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Others | 1.29 | 2.38 |
Healthcare | 91.09 | 91.66 |
Basic Materials | 5.09 | 5.96 |
Industrials | 1.81 | - |
Financial Services | 0.73 | - |
Top Comparisons
Invesco India - Invesco Global Equity Income Fund of Fund - Regular Plan - Growth
3Y Returns25.91%
ADITYA BIRLA SUN LIFE US TREASURY 3 10 YEAR BOND ETFS FUND OF FUNDS REGULAR PLAN GROWTH
3Y Returns0%
ICICI Prudential Commodities Fund - Growth Option
3Y Returns18.83%
ICICI Prudential ESG Exclusionary Strategy Fund - Growth
3Y Returns20.11%
Mahindra Manulife Large Cap Fund - Regular Plan - Growth
3Y Returns13.87%
BANDHAN Large Cap Fund - Regular Plan - Growth
3Y Returns16.29%
Nippon India Floater Fund - Regular Plan - Growth Option
3Y Returns7.71%
Axis Floater Fund - Regular Plan - Growth
3Y Returns7.95%